Biotech · Private company
Moberg Pharma AB
Track this companyFree. Adds Moberg Pharma AB to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- MOB015BPhase 3 · Distal Subungual OnychomycosisClinicalTrials.gov · fetched Nov 12, 2026
- MOB015BPhase 3 · OnychomycosisClinicalTrials.gov · fetched Nov 12, 2026
- MOB015B VehiclePhase 3 · Distal Subungual OnychomycosisClinicalTrials.gov · fetched Nov 12, 2026
- 0.2% SLSPhase 1 · ErythemaClinicalTrials.gov · fetched Nov 12, 2026
- MOB015BPhase 1 · ErythemaClinicalTrials.gov · fetched Nov 12, 2026
- MOB015B vehiclePhase 1 · ErythemaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)PHASE3 · UNKNOWN · started May 9, 2022ClinicalTrials.gov NCT05279846 · fetched Nov 12, 2026
- Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test DesignPHASE1 · COMPLETED · started Oct 19, 2017ClinicalTrials.gov NCT06369675 · fetched Nov 12, 2026
- Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test DesignPHASE1 · COMPLETED · started Oct 15, 2017ClinicalTrials.gov NCT06369727 · fetched Nov 12, 2026
- A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)PHASE3 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02859519 · fetched Nov 12, 2026